Capstone Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$4.62M Sell
17,024
-550
-3% -$145K 0.13% 194
2017
Q1
$4.8M Sell
17,574
-4,735
-21% -$1.34M 0.13% 184
2016
Q4
$6.33M Buy
22,309
+1,074
+5% +$318K 0.18% 132
2016
Q3
$6.65M Sell
21,235
-227
-1% -$67.2K 0.19% 124
2016
Q2
$5.19M Buy
21,462
+818
+4% +$216K 0.16% 147
2016
Q1
$5.37M Sell
20,644
-39
-0.2% -$10.3K 0.15% 159
2015
Q4
$6.34M Buy
20,683
+1,734
+9% +$498K 0.18% 135
2015
Q3
$5.53M Buy
18,949
+1,115
+6% +$368K 0.17% 139
2015
Q2
$7.2M Buy
17,834
+786
+5% +$315K 0.21% 130
2015
Q1
$7.2M Sell
17,048
-15
-0.1% -$5.91K 0.2% 123
2014
Q4
$5.79M Buy
17,063
+1,273
+8% +$412K 0.17% 153
2014
Q3
$5.22M Buy
15,790
+228
+1% +$75.2K 0.18% 131
2014
Q2
$4.91M Sell
15,562
-3,635
-19% -$1.09M 0.16% 153
2014
Q1
$5.87M Sell
19,197
-2,779
-13% -$882K 0.18% 134
2013
Q4
$6.14M Sell
21,976
-14,075
-39% -$3.64M 0.18% 129
2013
Q3
$8.68M Buy
36,051
+943
+3% +$211K 0.21% 95
2013
Q2
$7.55M Buy
+35,108
New +$7.5M 0.2% 97

Other funds holding BIIB

Capstone Asset Management's BIIB Position: Q2 2017 in Review

Capstone Asset Management reduced its Biogen (BIIB) stake by 3.1% in Q2 2017, selling an estimated $145K and leaving 17,024 shares worth $4.62M. The position accounts for 0.13% of the portfolio, ranked #194.

Capstone Asset Management first reported a position in BIIB in Q2 2013 and has held it in 17 quarters since. The position peaked at $8.68M in Q3 2013. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Capstone Asset Management held 17,024 shares of Biogen worth $4.62M as of Q2 2017.
  • Capstone Asset Management sold 550 Biogen shares in Q2 2017, an estimated $145K.
  • Biogen made up 0.13% of Capstone Asset Management's portfolio in Q2 2017, its #194 holding.
  • Capstone Asset Management first reported a position in Biogen in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Biogen position peaked at $8.68M in Q3 2013.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.